Trial intelligence / Profile preview

Skin Repairing Cream for Radiation Dermatitis in Breast Cancer

NCT07066280Phase 3Recruiting

Sponsor
Sun Yat-sen Memorial Hospital
Start
Apr 2025
Primary completion
Jan 2026
Countries
1
01

Overview

Phase 3, randomised, open-label trial in radiation dermatitis (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Incidence of acute radiation dermatitis (ARD) of grade 2-5. Started Apr 2025; status: recruiting.

02

Conditions

radiation dermatitis

Beyond the preview

Go deeper on NCT07066280.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07066280.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call